Literature DB >> 9817028

Percutaneous transluminal renal artery angioplasty using the coaxial technique. Ten years of experience from 591 procedures in 419 patients.

N E Kløw1, D Paulsen, K Vatne, B Rokstad, B Lien, P Fauchald.   

Abstract

PURPOSE: To evaluate the angiographic and clinical results of all percutaneous transluminal renal angioplasties (PTRAs) performed at one centre in Norway since the introduction of the method. Most of the PTRAs were performed with the coaxial technique (guiding-catheter-assisted angioplasty).
MATERIAL AND METHODS: In 419 patients, 595 PTRAs of 552 stenoses were performed from 1982 to 1993. The cases included 295 patients with arteriosclerotic vascular disease (AVD), 49 with fibromuscular dysplasia (FMD), and 74 transplantation patients (TX). Angiographic and clinical follow-up were undertaken.
RESULTS: Initial angiographic success was obtained in 92% of the patients and another 3% improved. The rates of immediate success were 92%, 98% and 84% for AVD, FMD and TX respectively. The corresponding rates for primary patency were 57%, 67% and 54%, and for secondary patency (after 1 to 6 angioplasties) 77%, 93% and 64%. Lower long-term results were obtained for: recanalized vessels; long lesions; bifurcation stenoses; stenoses in patients with abdominal aortic aneurysm; smaller vessels; and segmental branches in native and TX kidneys. Of 252 patients with hypertension, 8% were cured and another 58% improved. Of 215 patients with reduced renal function, 38% were normalized or improved and 42% unchanged. Major complications including 2 deaths were seen in 2.9% of the procedures and other complications in 4.7%.
CONCLUSION: PTRA with a guiding catheter can be performed in most patients with a high success rate and a low complication rate. This study points to two major problems with PTRA: the high restenosis rate and the low response to treatment of hypertension. The careful selection of patients for PTRA is important for increasing the success rate, and follow-up to detect restenosis is mandatory.

Entities:  

Mesh:

Year:  1998        PMID: 9817028     DOI: 10.3109/02841859809175483

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  7 in total

1.  Renal intervention to treat hypertension.

Authors:  Rajan A G Patel; Christopher J White
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

2.  Fibromuscular dysplasia presenting as a renal infarction: a case report.

Authors:  Annelies Van den Driessche; Erik Van Hul; Malika Ichiche; Gert A Verpooten; Jean-Louis Bosmans
Journal:  J Med Case Rep       Date:  2010-06-30

3.  Fibromuscular Dysplasia.

Authors:  David P Slovut; Jeffrey W Olin
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-06

Review 4.  Interventions for pediatric renovascular hypertension.

Authors:  Kevin E Meyers; Anne Marie Cahill; Christine Sethna
Journal:  Curr Hypertens Rep       Date:  2014-04       Impact factor: 5.369

5.  Fibromuscular dysplasia of the renal artery as a cause of secondary hypertension.

Authors:  Aneley Y Hundae; Christopher A Hebert; Jeffrey M Schussler
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-10

6.  Renal Subcapsular Hematoma Due to Reperfusion Injury Following Renal Angioplasty in Fibromuscular Dysplasia: A Dilemma in Diagnosis and Management.

Authors:  Vanlalmalsawmdawngliana Fanai; Animesh Mishra; Tony Ete; Amit Malviya; Arun Kumar
Journal:  Cureus       Date:  2022-03-21

7.  Percutaneous transluminal angioplasty of renal artery fibromuscular dysplasia: mid-term results.

Authors:  Hyo Jin Kim; Young Soo Do; Sung Wook Shin; Kwang Bo Park; Sung Ki Cho; Yeon Hyeon Choe; Sung Wook Choo; In Wook Choo; Duk Kyung Kim
Journal:  Korean J Radiol       Date:  2008 Jan-Feb       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.